Skip to main content
Clinical and Translational Medicine

Table 1 Characteristics of the patient groups

From: Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patients

Patient characteristics

Day surgery (n = 21)

Hospitalization surgery (n = 16)

P value

Age, y (median)

46 (35–71)

48.5 (38–75)

0.416*

Cancer stage

 I

10

14

 

 II

10

2

 

 III

1

0

 

Neoadjuvant chemotherapy

4

1

 

Surgical procedure

 Bp/SNB

17

11

0.041+

 Bp/SNB/Ax

0

3

 Bp/Ax

3

0

 Bt/SNB

0

2

 Bt/Ax

1

0

Subtype

 Luminal-A

9

5

0.763+

 Luminal-B

9

7

 Luminal-HER2

3

1

DCIS

0

3

 

Anesthetic technique

 Lidocaine/propofol/pethidine

21

  

 Propofol TCI: fentanyl/remifentanil

 

7

 

 Propofol TCI: fentanyl

 

4

 

 Sevoflurane/propofol/fentanyl/remifentanil

 

4

 

 Sevoflurane/propofol/fentanyl

 

1

 
  1. Ax axillary lymph node dissection, Bp partial resection of the breast, Bt total mastectomy of the breast, DCIS ductal carcinoma in situ, HER2 human epidermal growth factor-2, SNB sentinel lymph node biopsy, TCI target controlled infusion
  2. * Mann–Whitney U test
  3. +Chi square test
Back to article page